Ultragenyx Pharmaceutical
RARE
RARE
172 hedge funds and large institutions have $2.67B invested in Ultragenyx Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
9% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $12.3M
0% more funds holding
Funds holding: 172 → 172 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
172
Holding in Top 10
1
Calls
$13.4M
Puts
$12.3M
Top Buyers
| 1 | +$46.4M | |
| 2 | +$21M | |
| 3 | +$10.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.64M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$9.39M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$11.4M | |
| 3 | -$10.7M | |
| 4 |
BlackRock
New York
|
-$7.53M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$5.97M |